SLMUF
Slam Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in New York, New York. Slam Corp. operates as a subsidiary of Slam Sponsor, LLC.
SLMUF (SLMUF) - Net Assets
Latest net assets as of March 2025: $-20.42 Million USD
Based on the latest financial reports, SLMUF (SLMUF) has net assets worth $-20.42 Million USD as of March 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($23.56 Million) and total liabilities ($43.97 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-20.42 Million |
| % of Total Assets | -86.67% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 1976688.16 |
SLMUF - Net Assets Trend (2020–2024)
This chart illustrates how SLMUF's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for SLMUF (2020–2024)
The table below shows the annual net assets of SLMUF from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-19.86 Million | -133.66% |
| 2023-12-31 | $59.00 Million | -89.44% |
| 2022-12-31 | $558.86 Million | +3.46% |
| 2021-12-31 | $540.18 Million | +4564892.55% |
| 2020-12-31 | $11.83K | -- |
Equity Component Analysis
This analysis shows how different components contribute to SLMUF's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4242739700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $22.58 Million | % |
| Total Equity | $-19.86 Million | 100.00% |
SLMUF Competitors by Market Cap
The table below lists competitors of SLMUF ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
DETALION GAMES SA ZY -10
F:9XJ
|
$344.50K |
|
WEIR GROUP - Dusseldorf Stock Exchang
DU:42W
|
$344.80K |
|
Nordea Invest Nordic Small Cap KL 1
CO:NDINSCKL1
|
$344.80K |
|
Wealth Invest Metropolis GloAk
CO:WEIMGA
|
$344.97K |
|
PALFINGER - Dusseldorf Stock Exchang
DU:PFI
|
$344.34K |
|
Samkwang Glass Co. Ltd.
KQ:005090
|
$344.30K |
|
SOUTHWEST AIRLINES - Dusseldorf Stock Exchang
DU:SWN
|
$344.28K |
|
Asia Pacific Investama Tbk PT
JK:MYTX
|
$343.52K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SLMUF's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 58,996,732 to -19,859,490, a change of -78,856,222 (-133.7%).
- Net income of 1,828,661 contributed positively to equity growth.
- Share repurchases of 80,684,883 reduced equity.
- Other factors decreased equity by 0.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $1.83 Million | +9.21% |
| Share Repurchases | $80.68 Million | -406.28% |
| Total Change | $- | -133.66% |
Book Value vs Market Value Analysis
This analysis compares SLMUF's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $0.00 | $4.11 | x |
| 2021-12-31 | $7.52 | $4.11 | x |
| 2022-12-31 | $7.78 | $4.11 | x |
| 2023-12-31 | $2.52 | $4.11 | x |
| 2024-12-31 | $-1.21 | $4.11 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SLMUF utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (4.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 4.89% | 0.00% | 0.00x | 1.07x | $-27.62 Million |
| 2022 | 3.34% | 0.00% | 0.00x | 1.04x | $-37.20 Million |
| 2023 | 7.77% | 0.00% | 0.00x | 1.68x | $-1.31 Million |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $3.81 Million |
Industry Comparison
This section compares SLMUF's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $36,677,338
- Average return on equity (ROE) among peers: -64.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SLMUF (SLMUF) | $-20.42 Million | 4.89% | N/A | $344.45K |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $931.34 Million | 0.00% | 0.08x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $3.80 Million | -5.26% | 0.34x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $8.75K | -623.31% | 2.50x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-501.57K | 0.00% | 0.00x | $13.62K |
| ACRO Biomedical Co Ltd (ACBM) | $685.87K | -17.12% | 0.46x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-19.47K | 0.00% | 0.00x | $3.15K |